Skip to main content
Log in

Pimobendan Has a Potent Venodilating Action in Patients with Congestive Heart Failure

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Zelis R, Mason DT, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 1968;47:960-970.

    PubMed  Google Scholar 

  2. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-243.

    Article  PubMed  Google Scholar 

  3. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981;63: 645-651.

    PubMed  Google Scholar 

  4. Zelis R, Longhurst J, Capone RJ, Mason DT. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation 1974;50:137-143.

    PubMed  Google Scholar 

  5. Bohm M, Morano I, Pieske B, et al. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res 1991;68:689-701.

    PubMed  Google Scholar 

  6. Ruegg JC. Effects of new inotropic agents on Ca2+ sensitivity of contractile proteins. Circulation 1986;73(Suppl. III): III78-III83.

    PubMed  Google Scholar 

  7. Pouler H, Hanet C, Schroder E, et al. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure. J Cardiovasc Pharmacol 1989;14(Suppl.):S18-S22.

    PubMed  Google Scholar 

  8. Walter M, Liebens I, Goethals H, Renard M, Dresse A, Bernard R. Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses. Br J Clin Pharmacol 1988;25:323-329.

    PubMed  Google Scholar 

  9. Katz SD, Kubo SH, Jessup M, et al. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure. Am Heart J 1992;123:95-103.

    Article  PubMed  Google Scholar 

  10. Satoh H, Ikenouichi H, Aoyagi T, et al. Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure. J Cardiovasc Pharm 1990;15:317-322.

    Google Scholar 

  11. Kubo SH, Gollub S, Bourge R, et al. for the Pimobendan Multicenter Research Group. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. Circulation 1992;85:942-949.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsumoto, A., Momomura, Si., Yokoyama, I. et al. Pimobendan Has a Potent Venodilating Action in Patients with Congestive Heart Failure. Cardiovasc Drugs Ther 12, 595–597 (1998). https://doi.org/10.1023/A:1007755907820

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007755907820

Navigation